Hello Beacon Staff!!
Has there been any news you have seen about this agent since it received orphan drug status approval from the FDA last July?
It seems this agent is specific to tumor cells and enhances the immune system to attack tumor cells and does not attack normal plasma cells.
I have been looking for trials and outcomes without success.
Just curious if you have run across anything or if any of the Beacon advisors have experience using this agent.
|
||
Independent, up-to-date news and information for the multiple myeloma community. |
|
